Title:
PHARMACEUTICAL COMPOSITION OF NUCLEOSIDE-DERIVED COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/227106
Kind Code:
A1
Abstract:
The present invention provides a pharmaceutical composition of a nucleoside-derived compound, a preparation method therefor, and use thereof, and belongs to the field of medicines. The pharmaceutical composition comprises a compound SHEN26 and a pharmaceutically acceptable auxiliary material. The pharmaceutically acceptable auxiliary material comprises at least one selected from a diluent, a disintegrant, an adhesive, a lubricant, and a glidant. The pharmaceutical composition has the advantages of a high dissolution rate, good compatibility of raw and auxiliary materials, good stability, high bioavailability, and the like.
Inventors:
LI SHUO (CN)
LI GUANGUAN (CN)
LIU XINJUN (CN)
LI GUANGUAN (CN)
LIU XINJUN (CN)
Application Number:
PCT/CN2023/096521
Publication Date:
November 30, 2023
Filing Date:
May 26, 2023
Export Citation:
Assignee:
SHENZHEN ANTIV PHARMA CO LTD (CN)
International Classes:
A61P11/00; A61K31/53; A61P11/04; A61P11/14; A61P29/00; A61P31/14
Foreign References:
| CN112778310A | 2021-05-11 | |||
| CN113735862A | 2021-12-03 | |||
| CN113185519A | 2021-07-30 | |||
| US20220081462A1 | 2022-03-17 | |||
| CN113698405A | 2021-11-26 |
Attorney, Agent or Firm:
GUANGDONG JINTAI ZHIHUI PATENT & TRADEMARK AGENCY (GENERAL PARTNERSHIP) (CN)
Download PDF: